Novel Immunotherapy Drug Receives FDA Approval for the Treatment of Metastatic Melanoma
Friday, April 8, 2011 - 21:30
in Health & Medicine
On March 25, the US Food and Drug Administration announced that the drug ipilimumab (brand name Yervoy) was approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.